Tag: delayed

Categories
Politics

Costs in Bali Bombing Case Are Delayed at Guantánamo

Charges in Bali Bombing Case Are Delayed at Guantánamo

The three prisoners’ lawyers also told the judge that in 2020 the court’s official Indonesian translator believed that “the government is wasting money on these terrorists; they should have been killed long ago, ”adding that they had an affidavit from a witness who heard the comment. The public prosecutor’s office demands life imprisonment in the case.

Mr. Bin Lep’s attorney, Brian Bouffard, declared the Indonesian-American contract translator to be “irretrievably biased.” Mr. Bin Amin’s attorney, Christine Funk, asked why the prosecutors even needed an interpreter when bringing charges: “Are you spying on us? I do not know.”

The Trial Judge, Navy Cmdr. Hayes C. Larsen, tried to fix the problems. He gave the court’s official translation team a 10-minute break every 20 minutes. He urged defense attorneys to file legal motions if they believed there were problems of interpretation that required remedial action. And he postponed the reading of the charges until Tuesday, which was the reason for the hearing on Monday.

Both civilian and military defense attorneys, all paid by the Pentagon, said the case was still in its infancy. Prosecutors, they said, provided perhaps 2 percent of the pre-trial documents that could be used in the case, including reports of interrogations the FBI conducted with the detainees in 2007 shortly after they were transferred to military custody by the CIA was.

Mr. Hambali’s attorney, James R. Hodes, described the case as “absurd,” in part because of his client’s long prison term and nearly two decades late in bringing charges against him. He told reporters before the hearing that Mr. Hambali had been “brutalized” and had spent at least half of his detention in solitary confinement. He said the prisoner was due “an apology” and repatriation “to avoid being held in a cage on a Caribbean island.”

The hearings in Guantánamo took place mainly between English and Arabic, but also had translation problems. In 2015, one of the men accused of plotting the 9/11 attacks blurted out in court by the name of a translator – revealing that the linguist had previously worked for the CIA in a black place, his identity and derailed a week of hearings.

Categories
Health

FDA emergency use submission delayed to This fall

FDA emergency use submission delayed to Q4

Novavax announced that it will postpone filing its Covid-19 vaccine with the Food and Drug Administration for approval for emergency use until the fourth quarter.

The biotech company’s shares slipped 10% after the bell.

The company has applied for approval in India, Indonesia and the Philippines. Plans to submit the vaccine to the World Health Organization for emergency use are scheduled for August, Novavax announced.

WHO approval enables the vaccine to be distributed worldwide through vaccine exchange initiatives at the global agency.

Novavax data from clinical trials indicate that a booster dose of the candidate vaccine after two-dose treatment of an approved vaccine produces a 4-fold increase in neutralizing antibody levels.

The data also suggest that a booster dose of a Novavax vaccine six months after two-dose treatment of an approved vaccine could provide increased protection against the Delta variant and other variants.

Despite the delay in US approval, the company remains on track to produce 100 million cans per month through the end of the third quarter and 150 million per month through the end of the fourth quarter.

Categories
Health

Hong Kong journey bubble doubtless delayed, new restrictions

Hong Kong travel bubble likely delayed, new restrictions

A woman walks past a cordoned off Merlion Park in Singapore on June 12, 2020.

Facebook Facebook Logo Sign in to Facebook to connect with Suhaimi Abdullah Getty Images

SINGAPORE – Singapore’s benchmark index, the Straits Times, fell 3% after the government announced further tightening of Covid-19 restrictions and the likelihood of another delay in the air travel bubble with Hong Kong.

Aviation stocks were hit hard. Singapore Airlines was down 6.7%, while SATS, an aviation catering and airport ground handling company, was down 6.5%.

The Singapore government said Friday it was “very likely” that the Hong Kong travel bubble will not start as planned on May 26. The Southeast Asian country has tightened measures to curb the increasing cases of Covid locally, including stopping all dine-in services and limiting public gatherings to two.

The Singapore-Hong Kong air travel bubble would have allowed travelers to skip the quarantine. There have been several delays since it first launched in November 2020 as Hong Kong reported a resurgence in Covid-19 cases.

Both Singapore and Hong Kong are major Asian business centers with no domestic air travel markets. Your tourism and aviation industries, which are heavily reliant on international travel, have been hard hit by the pandemic.

Singapore Minister of Transport Ong Ye Kung said Hong Kong was “a very safe region” with few new Covid cases discovered daily. However, infections have risen in Singapore and the city-state is unlikely to reach the threshold to start the travel bubble, he added.

Singapore and Hong Kong have previously agreed that the travel arrangement will be suspended if the number of unlinked local Covid cases in both cities exceeds five on a moving average of seven days.

The Singapore Ministry of Health announced Thursday that it had confirmed 24 new cases of locally transmitted Covid-19 infections, four of which were not linked to previous cases. The number of new cases in the community rose to 71 in the past week – compared to 48 the week before, the ministry said.

On Thursday, the city-state confirmed a cumulative 61,453 Covid infections and 31 deaths, according to data from the Ministry of Health.

Meanwhile, Hong Kong identified three potential cases on Thursday, bringing the total number of confirmed or likely infections since the outbreak to 11,818, official data showed. The city has reported 210 deaths, according to the data.

Ong said he spoke with Edward Yau, Hong Kong’s Secretary for Trade and Economic Development, about the Covid situation in Singapore. Both sides will make a decision early next week on whether to continue the air travel bubble launch, Ong said.

Singapore is tightening restrictions

The Singapore government also announced that there will be more Covid-19 restrictions starting this weekend after local infections increase. The measures will take effect from this Sunday until June 13th.

The new measures include:

  • No eating in food and beverage establishments;
  • Smaller social gatherings: A maximum of two people are allowed, up from five previously;
  • All workers who can work from home must do so.

The government will review the measures halfway – or about two weeks later – to see if an adjustment is needed, said Lawrence Wong, Singapore’s education minister and co-chair of the Covid task force.

Before the announcement on Friday, Singapore had already tightened the restrictions since last weekend. These measures included pre-event testing for large gatherings and the closure of some indoor gyms.

Categories
World News

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Manufacturing facility Combine-Up

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up

Workers at a Baltimore plant that made two coronavirus vaccines accidentally merged the ingredients a few weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay approving the plant’s production lines.

The facility is operated by Emergent BioSolutions, a manufacturing partner of Johnson & Johnson and AstraZeneca, the Anglo-Swedish company whose vaccine is not yet approved for use in the United States. Federal officials attributed the error to human error.

The mix-up has delayed future shipments of Johnson & Johnson cans in the U.S. while the Food and Drug Administration investigates what happened. Johnson & Johnson has strengthened its control over the work of Emergent BioSolutions to avoid additional quality defects.

The mistake is a major embarrassment for both Johnson & Johnson, whose single-dose vaccine is credited with accelerating the national vaccination program, and Emergent, its subcontractor, who has received heavy criticism for its strong lobbying for federal contracts, particularly for the emergency Government Health Stock.

The bug does not affect any Johnson & Johnson cans currently shipped and used nationwide, including shipments that states are anticipating next week. All of these cans were made in the Netherlands, where the operations were fully approved by federal regulators.

More shipments of the Johnson & Johnson vaccine – expected to be 24 million doses next month – should come from the huge Baltimore facility. These supplies are now in question while quality control issues are being resolved according to those familiar with the matter.

Federal officials are still expecting enough doses from Johnson & Johnson and the other two approved coronavirus vaccine manufacturers to meet President Biden’s commitment to provide enough vaccines to immunize every adult by the end of May.

Pfizer is shipping its doses ahead of schedule, and Moderna is about to approve the supply of vaccine bottles of up to 15 doses instead of 10, further strengthening the country’s inventory.

The problems arose at a new facility the federal government hired last year to manufacture vaccines from Johnson & Johnson and AstraZeneca. The two vaccines use the same technology, which uses a harmless version of a virus – known as a vector – that is transferred into cells to make a protein, which then stimulates the immune system to produce antibodies. However, the Johnson and Johnson and AstraZeneca vectors are biologically different and not interchangeable.

At the end of February, one or more employees somehow mixed up the two during the production process and raised questions about training and supervision.

Vaccine manufacturing is a notoriously capricious science, and errors are often expected to occur and ruin batches. However, Emergent’s mistake went undetected for days until Johnson & Johnson quality controls discovered it, according to people familiar with the situation. By then, up to 15 million cans were contaminated, people said.

None of the cans ever left the plant and the lot has been quarantined.

Johnson & Johnson reported the mishap to federal regulators, who opened an investigation that delayed approval of the plant’s production lines. The company has increased the number of its own employees overseeing Emergent’s work and has introduced a number of new controls to protect against future errors.

Johnson & Johnson was already grappling with a manufacturing delay that caused the company to fail to meet its obligations to the federal government, but it appeared to be on track to catching up. 20 million doses had been administered by the end of March, and promises were made to deliver around 75 million additional doses by the end of May.

White House officials backed up their predictions in a phone call with governors on Tuesday. They forecast certain shipments from Pfizer and Moderna, but warned that Johnson & Johnson shipments would fluctuate.

In a statement late Wednesday, the company said it expected the steps it is now taking with Emergent would allow it to drop 24 million doses by the end of April, or whatever the federal government expects. However, this depends on Johnson & Johnson’s compliance with the Food and Drug Administration regulations.

Categories
Health

Elizabeth Holmes trial probably delayed as a result of she’s pregnant

Elizabeth Holmes denies destroying evidence in Theranos case

Elizabeth Holmes, founder and former executive director of Theranos, arrives for a hearing in the U.S. District Court in the Federal Building of Robert F. Peckham in San Jose, California on Monday, November 4, 2019.

Yichuan Cao | NurPhoto | Getty Images

Former Theranos CEO Elizabeth Holmes, whose criminal trial is due to begin in July, is asking for a delay because she is pregnant.

In a trial on Friday, her defense attorneys and prosecutors asked Judge Edward Davila to postpone the start of her trial for six weeks to begin August 31, 2021.

“On March 2, 2021, the defendant’s attorney notified the government that the defendant is pregnant and is expected to be due in July 2021,” Holmes prosecutors and attorneys write. “Both parties agree that in view of this development it is not possible to start the process on July 13, 2021.”

Further details were not immediately available.

The process has already been postponed three times due to the Covid-19 pandemic.

Holmes’ legal team was ready to address the issue of mental health as part of their defense strategy. In a previous court case, Holmes’ attorneys wrote that they intend to produce evidence “relating to a mental illness or a mental defect or other psychological condition of the defendant relating to the subject of guilt”.

This would be the expert testimony of Dr. Mindy Mechanic, a professor of clinical psychology at California State University Fullerton, who, according to the university’s website, “focuses on the psychosocial consequences of violence, trauma and victimization, with an emphasis on violence against women and other forms of violence interpersonal violence. “

The judge gave federal prosecutors the opportunity to self-examine Holmes’ mental health and to be examined by two experts, a psychologist and a psychiatrist.

Holmes and her former COO Sunny Balwani each face a dozen charges of fraud and 20 years in prison for falsely claiming that Theranos technology can perform dozens of blood tests on just a drop or two of blood.

The Silicon Valley startup was once valued at $ 9 billion before it closed in 2018.

Categories
Health

Covid vaccine shipments delayed by storm to reach by midweek: White Home advisor

Covid vaccine shipments delayed by storm to arrive by midweek: White House advisor

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are being prepared for shipment on December 13, 2020 at the Pfizer Global Supply Kalamazoo manufacturing facility in Portage, Michigan.

Morry Gash | Getty Images

All deliveries of Covid-19 vaccine doses delayed by the historic winter storm last week are expected to be delivered mid-week, Andy Slavitt, Senior White House Advisor for Covid-19 Response, said Monday.

Slavitt said Friday that shipments of about 6 million cans, equivalent to shipments worth about three days, were delayed by the storm.

“I reported on Friday that we would make up for the deliveries by the end of this week,” said Slavitt on Monday at the Covid-19 White House press conference. “We now assume that any remaining cans will be delivered by the middle of the week.”

He added that the federal government plans to ditch about 7 million vaccine doses on Monday, a combination of shots left behind from last week and some that should run out this week. He said the government’s ability to catch up quickly on the storm was thanks to members of the military and McKesson staff who the government hired to assist with distribution and logistics in getting the vaccine up and running.

“Seventy McKesson employees volunteered to work Saturday night and Sunday morning at 1am to prepare shipments for an 11am transit deadline,” he said, adding that UPS employees are also flexible on delayed deliveries could react.

Slavitt added that although the White House expected to catch up on the doses dispensed quickly, “it will take some time” for vaccination centers to catch up on vaccinations.

“We encourage vaccination centers to follow the same example of those who work longer hours to catch up on supplies by allowing more appointments to vaccinate the anxious public as soon as possible,” he said. Slavitt added that vaccination centers are still closed in some parts of the country that were particularly hard hit by the storm.

The pace of vaccination in Texas, rocked by the storm that left millions in the state without electricity, suffered badly. Slavitt said the 7-day average of daily doses received fell 31% over the past week.

Categories
Politics

Promotions for Feminine Generals Had been Delayed Over Fears of Trump’s Response

Promotions for Female Generals Were Delayed Over Fears of Trump’s Reaction

“It was about timing, not that it was women,” Miller, who served as acting Secretary of Defense for nearly three months, said in an interview.

Had Mr Trump won re-election, General Milley would most likely have sent the recommendations to the White House for approval, hoping for the best. But the General and Mr. Esper felt that under a Biden administration, the selection process was faced with a smoother selection process.

Mr. Biden and Mr. Austin could always select other candidates, but Mr. Esper and General Milley were confident that the new team would confirm their selection, which had been reviewed and evaluated over several months.

Col. Dave Butler, spokesman for General Milley, declined to comment on the article.

General Van Ovost is already a four-star officer who heads the Air Force Mobility Command at Scott Air Force Base, Illinois. Of the 43 four-star generals and admirals in the US military, she is the only woman. General Van Ovost, a seasoned Air Force Academy graduate who was selected to lead the multiservice transport command, also located at Scott Air Force Base, played out her strengths.

General Richardson is the three-star commander of the Army component of the Pentagon’s North Command in San Antonio, which plays an important role in the military support for FEMA’s Covid vaccination program.

“Very capable, great team builder,” said Anthony R. Ierardi, a retired commander of the Army’s First Cavalry Division, which included General Richardson, in an email. “Get things done.”

Categories
Business

EU piles stress on AstraZeneca over delayed vaccines, reveals particulars of contract

EU piles pressure on AstraZeneca over delayed vaccines, reveals details of contract

The President of the European Commission, Ursula von der Leyen, will give a lecture at the end of a video conference of the members of the European Council that dealt with the Covid 19 pandemic in Brussels on January 21, 2021.

OLIVIER HOSLET | AFP | Getty Images

LONDON – The European Union released an edited version of the contract it signed with AstraZeneca on Friday as the bloc put pressure on the drug maker to deliver the promised Covid vaccine shipments.

The EU, which has been criticized for its slow adoption of vaccinations, was hit with a blow by AstraZeneca last week when the company said it could only deliver a fraction of the shots it agreed to for the first quarter.

AstraZeneca has denied it failed to deliver on its commitments, stating that shipments to the 27-nation bloc were targets rather than promises. The company also cited production problems at its European plants for the delays.

The European Commission, the EU executive, welcomed AstraZeneca’s commitment to greater transparency after the company agreed to publish details of the agreement. AstraZeneca was not immediately available to leave comments when CNBC contacted them.

The contract, which was signed on August 27, provides for AstraZeneca to undertake to the best of its ability to build capacity to produce 300 million doses of vaccine, with the Commission having the option to order an additional 100 million doses.

In the case of AstraZeneca, the agreement defines “best effort” as the activities a company with similar resources would undertake in the development and manufacture of its vaccine.

This includes “bearing in mind the urgent need for a vaccine to end a global pandemic that is creating serious public health problems, restrictions on personal freedoms and economic impacts around the world, but considering its effectiveness and safety”.

The contract states that AstraZeneca will use its “best possible efforts” to manufacture the vaccine at manufacturing facilities in the EU. The deal also provides for this to include plants based in the UK, although the country left the bloc last year.

AstraZeneca has been told to send some of the UK-made cans to the block, but the company said a separate deal with the UK prevented that.

The European Medicines Agency is expected to make a decision on Friday on whether the AstraZeneca vaccine will actually be approved for use.

International Competition Concerns

The President of the European Commission, Ursula von der Leyen, said on Friday morning on German radio: “There are binding orders and the contract is crystal clear.”

“AstraZeneca also explicitly assured us in this contract that no other obligations would prevent the fulfillment of the contract,” she said, according to Reuters.

Von der Leyen of the EU claimed the deal included clear delivery amounts for December and the first three quarters of 2021.

Earlier this week, Pascal Soriot, CEO of AstraZeneca, said the EU contract was based on what is known as a “best effort” clause and did not officially oblige the drug maker to a specific delivery schedule.

The EU von der Leyen rejected this proposal on Friday, adding that the clause would only apply if it was unclear whether AstraZeneca could develop a safe and effective vaccine. She also claimed that the contract specifically mentioned four manufacturing facilities that would supply the vaccine to Europe, two of which are in the UK.

A look at the headquarters of the British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca as a Covid-19 vaccine developed by AstraZeneca and inspected in Brussels, Belgium on January 28, 2021.

Dursun Aydemir | Anadolu Agency | Getty Images

EU officials have indicated that deliveries from the UK to Europe could be rerouted if delays in European production persist.

UK Prime Minister Boris Johnson said he remained “confident” of delivering the AstraZeneca vaccine developed in partnership with Oxford University. Johnson added that he was “very pleased” that the country was among the fastest in Europe to introduce the vaccine.

The UK has the second highest number of confirmed Covid cases in Europe after Russia, recording the highest number of coronavirus-related deaths of any European nation and the fifth highest worldwide.

The EU of around 450 million people is struggling to get its vaccinations up and running as it is insufficiently supplied and is currently lagging far behind countries like Israel and the UK in delivering vaccines to its citizens.

Vaccine maker Pfizer-BioNTech initially delivered a blow, announcing it would temporarily cut production to improve its production capacity in Belgium. This was followed by AstraZeneca last Friday, which reduced its delivery estimates for the region.

An unnamed senior EU official told Reuters that the bloc expected about 80 million doses by March but had been told it would only receive 31 million doses instead. The company has not confirmed the quantities concerned.

A deepening dispute between the EU and AstraZeneca has raised concerns about international competition for limited vaccine supplies. Hopefully the vaccinations can help end the coronavirus pandemic.

– CNBC’s Holly Ellyatt contributed to this report.

Categories
Business

‘A Quiet Place II’ delayed once more, units sights on September launch

'A Quiet Place II' delayed again, sets sights on September release

Emily Blunt, Millicent Simmonds and Noah Jupe star in “A Quiet Place Part II”.

Paramount Pictures

“A Quiet Place Part II” is the latest Hollywood movie to advance to box office release worldwide as the coronavirus pandemic rages on in the US. This is the third time the movie has been postponed due to the outbreak.

Paramount’s post-apocalyptic thriller will now premiere on September 17th. The film should last in theaters on April 23.

The film is the highly anticipated sequel to John Krasinski’s directorial debut, “A Quiet Place,” which introduced moviegoers to a world where deadly but blind creatures hunt based on sound only. The film starred actress Emily Blunt alongside teenage deaf actress Millicent Simmonds and a young English actor named Noah Jupe. All three are returning for the sequel.

The first A Quiet Place, on a budget of just $ 17 million, grossed more than $ 340 million at the global box office as moviegoers flocked to theaters to watch the exciting film on the big screen and in large groups experience.

This is a likely reason why Paramount, which has been actively selling a number of theatrical titles to streaming services over the past year, decided to postpone the release of the sequel.

In the past, Studio Aaron Sorkins sold “The Trial of the Chicago 7” to Netflix and “Coming 2 America” ​​and “Without Remorse” to Amazon.

The commercial success of “A Quiet Place” and Krasinski’s desire to have the film play on the big screen could keep the film out of the streaming market for the time being.

This is what the 2021 calendar looks like after “A Quiet Place II” has been postponed.